Skip to main content

Medical Legal Aspects of Quality Improvement

  • Chapter
  • First Online:
Colorectal Cancer Screening

Abstract

The use of quality improvement tools such as clinical practice guidelines and quality measures can improve patients’ clinical outcomes and reduce the incidence of adverse events. In addition to improving patient care, properly structured quality improvement policies can also reduce physician liability. If a physician is sued for malpractice, proof that the physician complied with a guideline or quality measure will help prove lack of fault for a negative outcome. However, guidelines and quality measures are double-edged swords. As quality measures and guidelines become established, courts may adopt them as de facto standards of care, and physician noncompliance may lead to liability during a malpractice trial. The careful gastroenterologist will need to keep up with quality measures both to provide good patient care and to manage risk.

This chapter reviews potential legal risk areas associated with quality improvement measures for colonoscopy. The first part introduces the basic legal concepts used in malpractice cases. The second part examines clinical practice guidelines and quality measures and their use by courts to define the standard of care. The third part discusses the confidentiality protection afforded by peer review to data gathered for health-care quality improvement. The fourth part discusses specific aspects of CRC screening where physicians may face liability for noncompliance with practices defined in guidelines, quality measures, or other quality-improvement-related recommendations. Part five addresses liability risks and other potential problems associated with the use of financial incentives to encourage physicians to meet specified quality measures and benchmarks. Finally, part six presents the concept of risk management programs and their use in limiting a physician’s malpractice risk.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Hood v. Phillips, 554 S.W.2d 160, 165 (Texas 1977).

  2. 2.

    Salgo v Leland Stanford Jr. University Board of Trustees 317 P.2d 170 (California 1957).

  3. 3.

    Committee to Advise the Public Health Service on Clinical Practice Guidelines, Institute of Medicine, Clinical Practice Guidelines: Directions for a New Program, at 8 (Marilyn J. Field and Kathleen N. Lohr eds., 1990)

  4. 4.

    I.e., the ACG in its guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee, using expert opinion and data available at the time. The ACG then seeks the approval of the governing boards of the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the American Association for the Study of Liver Diseases. See id.

  5. 5.

    See May v. Moore 424 So 2d 596 (Ala 1982) (“there is no tenable policy reason why a physician should not be required to keep abreast of the advancements of his profession.”).

  6. 6.

    Some states, including Maine, Florida, Kentucky, and Minnesota have created statutes to permit physicians to use adherence to CPGs as an affirmative defense in malpractice actions.

  7. 7.

    See Hood v Phillips, 554 S.W.2d 160, 165 (TX, 1977) (“A physician is not guilty of malpractice where the method of treatment used is supported by a respectable minority of physicians, as long as the physician has adhered to the acceptable procedures of administering the treatment as espoused by the minority”).

  8. 8.

    See Helling v. Carey (519 P.2d 981 Wash. 1974).

  9. 9.

    See, e.g., Frakes v. Cardiology Consultants, PC, 1997 Tenn App 597 (Tenn Ct App 1997) (holding that the guidelines at issue, which were promulgated by the American College of Cardiology and American Heart Association, were recognized by a majority of experts as the standard of care for the profession and therefore were relevant and had authoritative power as substantive evidence in malpractice litigation).

  10. 10.

    American Gastroenterological Association, Guidelines, available at http://www.gastro.org/practice/medical-position-statements.

  11. 11.

    See Virmani v. Novant Health, Inc., 259 F.3d 284, 290 (4th Cir. 2001) (“[A]ll fifty states and the District of Columbia have recognized the [peer review] privilege.”); Health Care Quality Improvement Act of 1986 (HCQIA), 42 U.S.C. § 11101 et seq.

  12. 12.

    See also generally Bredice v. Doctors Hosp., Inc., 50 F.R.D. 249–50 (D.D.C. 1970); Claypool v. Mladineo, 724 So. 2d 373, 388 (Miss. 1998); Cruger v. Love, 599 So. 2d 111, 114–15 (Fla. 1992); Trinity Med. Ctr., Inc. v. Holum, 544 N.W.2d 148, 155 (N.D. 1996); Young v. Saldanha, 431 S.E.2d 669 (W. Va. 1993); Moretti v. Lowe, 592 A.2d 855, 857 (R.I. 1991); HCA Health Servs. of Virginia, Inc. v. Levin, 530 S.E.2d 417, 420 (Va. 2000); Glover v. Griffin Health Servs., No. X06CV055001692S, 2007 WL 3173658 at *4 (Conn. Super. Oct. 11, 2007).

  13. 13.

    Orgavanyi v. Henry County Health Center, 2010 WL 5394785 (Iowa Ct. App. Dec. 22, 2010); Legg v Hallet, No. 07AP-170 (Ohio Ct. App. Dec. 11, 2007); Columbia/HCA Health Care Corporation v. Eighth Judicial District Court, 936 P.2d 844 (Nev. 1997).

  14. 14.

    Schleondorff v Society of New York Hospital, 211 N.Y.125, 105 N.E. 92 (1914), New York.

  15. 15.

    Salgo v. Leland Stanford Jr. University Board of Trustees 317 P.2d 170, California.

  16. 16.

    Canterbury v. Spence 464 F.2d 772(D.C. Cir. 1972).

  17. 17.

    One possible example: “The information you received noted that no test is perfect, including this endoscopy, and our staff have reviewed the risks of colonoscopy, including bleeding, perforation, infection, heart or respiratory complications, missed diagnosis, incomplete procedure, and sedation risks. Do you have any questions for me?”

  18. 18.

    Mitchell v. United States, 141 F3d 8; 49 (1st Cir 1998).

  19. 19.

    OA is financially rewarding for practices.

  20. 20.

    i.e., accomplishing screening colonoscopy in a single visit.

  21. 21.

    See, e.g., ASGE Practice Guidelines on Open Access Endoscopy, available at http://www.asge.org/assets/0/71542/71544/04fc88121fec40b6b99883384beb5cf6.pdf.

  22. 22.

    Informed consent is particularly important and the patient must be given sufficient time before the procedure to ask questions or inform the physician of additional concerns or complications the patient might have. The informed consent process as it relates to OA will be detailed in section c., infra.

  23. 23.

    Safer v. Pack, 677 A2d 1188, cert. Den’d, 683 A2d1163 (New Jersey 1996).

  24. 24.

    (see the article by Greenwood elsewhere in this issue).

References

  1. Feld AD, Moses RE. Most doctors win: what to do if sued for malpractice. Am J Gastroenterol. 2009;6:1346–51.

    Article  Google Scholar 

  2. Moses RE, Feld AD. Legal risks of clinical practice guidelines. Am J Gastroenterol. 2008;103:7–11.

    Article  PubMed  Google Scholar 

  3. Gerstnberger PD, Plumeri PL. Malpractice claims in gastrointestinal endoscopy: analysis of an insurance industry database. Gastrointest Endosc. 1993;39:132–8.

    Article  Google Scholar 

  4. American College of Gastroenterology. Diagnosis, treatment, and surveillance for patients with colorectal polyps. Am J Gastroenterol. 2000;95:3053–63.http://gi.org/guideline/diagnosis-treatment-and-surveillance-for-patients-with-colorectal-polyps/.

    Article  Google Scholar 

  5. Finder JM. The future of practice guidelines: should they constitute conclusive evidence of the standard of care? Health Matrix. 2000;10:67–77.

    CAS  PubMed  Google Scholar 

  6. Kozlick D. Clinical practice guidelines and the legal standard of care: warnings, predictions, and interdisciplinary encounters. Health Law J. 2011;19:125–133.

    PubMed  Google Scholar 

  7. Shekelle PG, et al. Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated? J Am Med Assoc. 2001;286:1461. (finding that three quarters of the reviewed guidelines needed updating, and after 5.8 years 50 % of the guidelines were out of date).

    Article  CAS  Google Scholar 

  8. Sniderman AD, Furberg CD. Why guideline-making requires reform. J Am Med Assoc. 2009;301:429. (noting that as of 2009 the National Guidelines Clearinghouse had registered 2373 guidelines produced by 285 different organizations).

    Article  CAS  Google Scholar 

  9. Furrow BR, et al. Health Law. 1995;6–2:361–2.

    Google Scholar 

  10. Rosoff AJ. Evidence-based medicine and the law: the courts confront clinical practice guidelines. J Health Polit Policy Law. 2001;26:327–38.

    Article  CAS  PubMed  Google Scholar 

  11. Mello MM. Of swords and shields: the role of clinical practice guidelines in medical malpractice litigation. Univ Pa Law Rev. 2001;149(3):645, 665. (“many courts have gone so far as to recognize CPGs offered by the plaintiff as establishing a rebuttable presumption of the standard of care.”).

    Article  Google Scholar 

  12. Agency for Healthcare Research and Quality (AHRQ). Variety of measures in national quality measures clearing house. http://www.qualitymeasures.ahrq.gov/tutorial/varieties.aspx. Accessed 26 Sept 2014.

  13. Brotman M, Allen JI, Bickston SJ, et al. AGA task force on quality in practice: a national overview and implications for GI practice. Gastroenterology. 2005;129(1):361–9.

    Article  PubMed  Google Scholar 

  14. Rex DK, Bond JA, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations for the US multisystem task force on colorectal cancer. Am J Gastroenterol. 2002;97:1296–308.

    Article  PubMed  Google Scholar 

  15. Lieberman DA, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system report of the quality assurance task group on the national colorectal cancer round table. Gastrointest Endosc. 2007;65:757–66.

    Article  PubMed  Google Scholar 

  16. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.

    Google Scholar 

  17. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2000.

    Google Scholar 

  18. Miller LK. Protecting and preserving the peer review privilege: solutions for corporate counsel representing hospitals. Health care corporations, and health care providers, DRI defense library series. 2008. (citing Pardo v. Gen. Hosp. Corp., 841 N.E.2d 692 (Mass. 2006)).

    Google Scholar 

  19. Feld AD. Informed consent for colonoscopy. In: Waye J, Rex DK, Williams CB, editors. Colonoscopy: principles and practice. Malden: Blackwell Publishing; 2009. p. 79–89.

    Google Scholar 

  20. Berg JW, Appelbaum PS, Lidz CW, et al. Informed consent: legal theory and clinical practice. 2nd ed. Oxford: Oxford University Press; 2001.

    Google Scholar 

  21. Gatter R. Informed consent law and the forgotten duty of physician inquiry. Loyola Univ Chic Law J 2000;31:557.

    CAS  PubMed  Google Scholar 

  22. Davenport J, Lippman H. Sued for misdiagnosis? It could happen to you. J Fam Pract. 2010;59(9):498–508.

    PubMed  Google Scholar 

  23. Gandhi TK, et al. Missed and delayed diagnoses in the ambulatory setting. Ann Intern Med. 2006;145(7):488–96. (In a review of 181 closed malpractice claims for missed or delayed diagnosis, the authors found an average of three contributing errors in each case).

    Article  PubMed  Google Scholar 

  24. Mello MM, Studdert DM. Deconstructing negligence: the role of individual and system factors in causing medical injuries. Georgetown Law J. 2008;96:599–623. (In a review of 889 malpractice cases, not limited to claims for missed and delayed diagnosis, the authors found an average of 3.14 contributing errors in each case).

    Google Scholar 

  25. Wahls TL, Peleg I. Patient and system-related barriers for the earlier diagnosis of colorectal cancer. BMC Fam Pract 2009;10:65. http://www.biomedcentral.com/1471-2296/10/65.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Feld KA, Feld AD. Risk management and legal issues for colonoscopy. Gastrointest Endosc Clin N Am. 2010;20(4):595–6.

    Article  Google Scholar 

  27. Rex DK, Bond JH, Feld AD. Medical legal risks of incident cancers after clearing colonoscopy. Am J Gastroenterol. 2001;96(4):952–7.

    Article  CAS  PubMed  Google Scholar 

  28. Schoen C, et al. Primary care and health system performance: adults’ experiences in five countries. Health Aff. 2004. (A survey of patients in five countries found that 9 to 15 % of adults treated as outpatients received incorrect results or delayed notification of abnormal results).

    Google Scholar 

  29. Wahls TL, Peleg I. Patient and system-related barriers for the earlier diagnosis of colorectal cancer. BMC Fam Pract. 2009;10:65. http://www.biomedcentral.com/1471-2296/10/65.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Boohaker EA, et al. Patient notification and follow-up of abnormal test results: a physician survey. Arch Intern Med. 1996;156:327–9.

    Article  CAS  PubMed  Google Scholar 

  31. Potchen EJ, et al. Mammography and malpractice. Am J Roentgenol. 1991;156:475–80.

    Article  CAS  Google Scholar 

  32. Berlin L. Malpractice and radiologists. Am J Roentgenol. 1980;135:587–91.

    Article  CAS  Google Scholar 

  33. Gallegos A. Medical liability: missed follow-ups a potent trigger of Lawsuits. Am Med News. 2013.

    Google Scholar 

  34. Giblin EB, Christina MS. Does patient responsibility still exist? AAOS Now 2012. (The authors discuss a 2010 committee opinion of the American College of Gynecology stating that all physicians have a duty to inform patients of the importance of returning for follow-up. The authors state that all physicians must comply with this opinion to avoid malpractice liability, because plaintiffsĘĽ lawyers are likely to point to the opinion as evidence of physiciansĘĽ standard of care).

    Google Scholar 

  35. Howard ML. What to do until the lawyers arrive. In: Professional liability handbook. American Academy of Otolaryngology—Head and Neck Surgery; 2001. http://www.entnet.org/practice/upload/professional-liability-handbook.pdf.

  36. Cohen LB, DeLegge M, Aisenberg J, et al. AGA institute review of endoscopic sedation. Gastroenterology 2007;133:675–701.

    Article  CAS  PubMed  Google Scholar 

  37. Feld AD. Medicolegal implications of colon cancer screening. Gastrointest Endosc Clin N Am. 2002;12(1):171–9.

    Article  PubMed  Google Scholar 

  38. Feld AD. Malpractice risks associated with colon cancer and inflammatory bowel disease. Am J Gastroenterol. 2004;9:1641–4.

    Article  Google Scholar 

  39. Mahajan RJ, Marshall JB. Prevalence of open access gastrointestinal endoscopy in the United States. Gastrointest Endosc. 1997;46:21–6. (According to the survey, approximately 60 % of respondents use some form of Open Access in their practice).

    Article  CAS  PubMed  Google Scholar 

  40. Custers T, et al. Selecting effective incentive structures in healthcare: a decision framework to support healthcare purchasers in finding the right incentives to drive performance. BMC Health Serv Res. 2008;8:66.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Rosenthal MB, et al. Paying for quality: providersʼ incentives for quality improvement. Health Aff. 2004;23:127–41.

    Article  Google Scholar 

  42. Baker G, Carter B. Provider pay-for-performance incentive programs: 2004 national study results. San Francisco: Med-Vantage; 2005.

    Google Scholar 

  43. Monica J. Smith. Higher reimbursement an added bonus of quality benchmarking program. Gastroenterol Endosc News. 2013;64:8.

    Google Scholar 

  44. Li J, et al. Physician response to pay-for-performance: evidence from a natural experiment. National Bureau of Economic Research (NBER) working paper no. 16909; 2011.

    Google Scholar 

  45. Lindenauer PK, et al. Public reporting and pay for performance in hospital quality improvement. New Eng J Med. 2007;356(5):486. (In a study of hospitals instituting pay-for-performance, the researchers found that physicians at those hospitals did in fact perform better on a variety of individual and composite quality measures than physicians at non-pay-for-performance hospitals).

    Article  CAS  PubMed  Google Scholar 

  46. Johnson DA. Pay for performance: ACG guide for physicians. Am J Gastroenterol. 2007;102(10):2119–20.

    Article  PubMed  Google Scholar 

  47. Cook SL. Will pay-for-performance be worth the price to medical providers? A look at pay-for-performance and its legal implications for providers. Ann Health Law 2007;16:163–80.

    PubMed  Google Scholar 

  48. Deas T, Pike I. Benchmarking to excellence: using quality indicators to improve performance. Endoeconomics. 2010;19:19–20. (using QIQuIC data to suggest a target rate of 94 % for cecal intubation).

    Google Scholar 

  49. Petrini J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2006;63(4):16–21. (suggesting a target cecal intubation rate of 95 % for CRC screenings in healthy adults, and a 90 % cecal intubation rate for all colonscopy).

    Article  Google Scholar 

  50. Pengalis SE, Wachsman HF. American law of medical malpractice. 2nd ed. 1992. p. 49.

    Google Scholar 

  51. Petrini DA, Petrini JL. Risk assessment and management for endoscopists in an ambulatory surgery center. Gastrointest Endosc Clin N Am. 2006;16:801–15. (Additional factors include: processes for consent, disclosure, and decision making; and methods to obtain family history and manage high-risk conditions).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew D. Feld .

Editor information

Editors and Affiliations

Additional information

Disclaimer: This chapter is written for educational purposes, and should not be construed to provide specific legal advice; for that the reader will need to consult his/her own health-care attorney

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Feld, K., Blankstein, S., Feld, A. (2015). Medical Legal Aspects of Quality Improvement. In: Shaukat, A., Allen, J. (eds) Colorectal Cancer Screening. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2333-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2333-5_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2332-8

  • Online ISBN: 978-1-4939-2333-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics